- Home
- GCT vs KURA Comparison
GCT vs KURA Comparison
Compare GCT & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCT
- KURA
- Stock Information
- Founded
- GCT 2019
- KURA 2014
- Country
- GCT United States
- KURA United States
- Employees
- GCT N/A
- KURA N/A
- Industry
- GCT Catalog/Specialty Distribution
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GCT Consumer Discretionary
- KURA Health Care
- Exchange
- GCT Nasdaq
- KURA Nasdaq
- Market Cap
- GCT 502.5M
- KURA 492.9M
- IPO Year
- GCT 2022
- KURA N/A
- Fundamental
- Price
- GCT $17.93
- KURA $6.30
- Analyst Decision
- GCT Buy
- KURA Strong Buy
- Analyst Count
- GCT 2
- KURA 12
- Target Price
- GCT $20.50
- KURA $24.50
- AVG Volume (30 Days)
- GCT 864.2K
- KURA 1.2M
- Earning Date
- GCT 05-12-2025
- KURA 05-01-2025
- Dividend Yield
- GCT N/A
- KURA N/A
- EPS Growth
- GCT 19.58
- KURA N/A
- EPS
- GCT 3.07
- KURA N/A
- Revenue
- GCT $1,181,871,000.00
- KURA $67,991,000.00
- Revenue This Year
- GCT $1.98
- KURA $171.90
- Revenue Next Year
- GCT $6.50
- KURA $60.51
- P/E Ratio
- GCT $5.83
- KURA N/A
- Revenue Growth
- GCT 42.89
- KURA N/A
- 52 Week Low
- GCT $11.17
- KURA $5.41
- 52 Week High
- GCT $34.28
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- GCT 59.47
- KURA 54.15
- Support Level
- GCT $17.41
- KURA $5.56
- Resistance Level
- GCT $18.55
- KURA $5.84
- Average True Range (ATR)
- GCT 0.86
- KURA 0.36
- MACD
- GCT -0.07
- KURA 0.02
- Stochastic Oscillator
- GCT 53.85
- KURA 79.61
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.